Clustering of comorbid conditions among women who carry an FMR1 premutation

Abstract

Although some women with a premutation experience complex health outcomes, most carriers report only minimal comorbid conditions. Further, women with symptoms of FXTAS appear to be distinct from women with symptoms of FXPOI.